Antipseudomonal beta-lactams.
D000900:Anti-Bacterial Agents; D002438:Cefoperazone; D002439:Cefotaxime / Q000031:analogs & derivatives / Q000627:therapeutic use; D002441:Cefsulodin; D002442:Ceftazidime; D002443:Ceftriaxone; D002511:Cephalosporins / Q000627:therapeutic use; D002513:Cephamycins / Q000627:therapeutic use; D004355:Drug Stability; D007769:Lactams; D009070:Moxalactam; D010406:Penicillins / Q000627:therapeutic use; D011552:Pseudomonas Infections / Q000188:drug therapy*; D011550:Pseudomonas aeruginosa / Q000201:enzymology; D013845:Thienamycins; D001618:beta-Lactamases / Q000494:pharmacology; D047090:beta-Lactams / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D002513:Cephamycins; D007769:Lactams; D010406:Penicillins; D013845:Thienamycins; D047090:beta-Lactams; C020600:CI 867; D002443:Ceftriaxone; C027318:nocardicin; D002438:Cefoperazone; D002442:Ceftazidime; D001618:beta-Lactamases; D002439:Cefotaxime; D002441:Cefsulodin; D009070:Moxalactam; C015537:thienamycin